Professional cannabis stock analysis and actionable trading ideas
for one of the greatest investment opportunities of our time!
Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Michael Vodicka is a licensed investment advisor with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
IF You Know Why, When, and Which Stocks Are Worth The Hype
The US cannabis industry quietly took a big step towards legalizing cannabis.
A bipartisan group of legislators reintroduced the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act to the House. This bill could have an enormous impact on the cannabis industry.
If this latest cannabis
Florida’s cannabis market is about to be unleashed and I think this early industry leader is ready to cash in on the booming trend.
Back in 2016, Florida created a law that restricted state cannabis companies to operating 25 dispensaries. That cap was designed to expand as the number of medical cannabis patients increased. Today, the cap stands at 35.
Continue “Florida’s Largest Cannabis Player Set to Expand to 49 Dispensaries”
On February 2, 2019, I sent a member alert that we were buying Blueberries Medical Corp. (BBM) for our model portfolio.
I knew this rare play on the high-growth Colombian cannabis industry would be a highly speculative trade, but I believed that we’d see a move towards the upside.
Continue “BBM Trade Closed With 92% Gain”